perifosine has been researched along with n-octadecylphosphocholine in 2 studies
| Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (n-octadecylphosphocholine) | Trials (n-octadecylphosphocholine) | Recent Studies (post-2010) (n-octadecylphosphocholine) |
|---|---|---|---|---|---|
| 245 | 31 | 140 | 18 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mravljak, J; Pecar, S; Zeisig, R | 1 |
| Croft, SL; Kayser, O; Lemke, A; Seifert, K | 1 |
2 other study(ies) available for perifosine and n-octadecylphosphocholine
| Article | Year |
|---|---|
Synthesis and biological evaluation of spin-labeled alkylphospholipid analogs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclic N-Oxides; Drug Screening Assays, Antitumor; Hemolysis; Humans; Liposomes; Micelles; Organophosphates; Phospholipids; Phosphorylcholine; Solutions; Spin Labels; Structure-Activity Relationship; Surface-Active Agents | 2005 |
Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives.
Topics: Animals; Antiprotozoal Agents; Cell Line, Tumor; Cell Survival; Cricetinae; Humans; Inhibitory Concentration 50; Leishmania donovani; Lethal Dose 50; Molecular Structure; Phospholipids; Structure-Activity Relationship | 2007 |